Atricure Inc. buy JPMorgan Chase & Co.
Start price
16.12.25
/
50%
€34.60
Target price
16.12.26
€40.85
Performance (%)
-33.53%
Price
22.04.26
€23.00
Summary
This prediction is currently active. Massive losses of -33.53% have been the result for the BUY prediction by JPMorgan_Chase___Co_. This prediction currently runs until 16.12.26. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Atricure Inc. | -5.738% | -5.738% |
| iShares Core DAX® | 0.411% | 8.821% |
| iShares Nasdaq 100 | 3.678% | 10.820% |
| iShares Nikkei 225® | 2.701% | 15.247% |
| iShares S&P 500 | 2.445% | 7.933% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Atricure Inc. diskutieren
AtriCure (NASDAQ:ATRC) had its price target raised by analysts at JPMorgan Chase & Co. from $42.00 to $48.00. They now have an "overweight" rating on the stock.
Ratings data for ATRC provided by MarketBeat